Coronavirus-disease-19 (COVID-19) continues to affect millions of individuals worldwide. Antiviral activity of mouthrinses remains an important research area as the oral cavity is a site of SARS-CoV-2 initial replication. The aim of this study was to assess the effectiveness of three different mouthrinses in reducing the oral/oropharyngeal SARS-CoV-2 viral load.
Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study / Fantozzi, Paolo Junior; Pampena, Emanuele; Pierangeli, Alessandra; Oliveto, Giuseppe; Sorrentino, Leonardo; Di Vanna, Domenico; Pampena, Riccardo; Lazzaro, Alessandro; Gentilini, Elio; Mastroianni, Claudio Maria; D'Ettorre, Gabriella; Polimeni, Antonella; Romeo, Umberto; Villa, Alessandro. - In: AMERICAN JOURNAL OF OTOLARYNGOLOGY. - ISSN 0196-0709. - 43:6(2022), p. 103549. [10.1016/j.amjoto.2022.103549]
Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study
Fantozzi, Paolo Junior;Pampena, Emanuele;Pierangeli, Alessandra;Oliveto, Giuseppe;Sorrentino, Leonardo;Di Vanna, Domenico;Pampena, Riccardo;Lazzaro, Alessandro;Gentilini, Elio;Mastroianni, Claudio Maria;D'Ettorre, Gabriella;Polimeni, Antonella;Romeo, Umberto;
2022
Abstract
Coronavirus-disease-19 (COVID-19) continues to affect millions of individuals worldwide. Antiviral activity of mouthrinses remains an important research area as the oral cavity is a site of SARS-CoV-2 initial replication. The aim of this study was to assess the effectiveness of three different mouthrinses in reducing the oral/oropharyngeal SARS-CoV-2 viral load.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
